Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model-Reference-Cited by-同舟云学术

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model

Published:2015-01-13 Issue:3 Volume:55 Page:532-543
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Okoye Obi T.¹^ORCID,Reddy Heather²,Wong Monica D.¹,Doane Suzann²,Resnick Shelby¹,Karamanos Efstathios¹,Skiada Dimitra¹,Goodrich Raymond²,Inaba Kenji¹

Affiliation:

1. Division of Trauma Surgery and Surgical Critical Care; Department of Surgery; Keck School of Medicine of University of Southern California; Los Angeles California

2. Terumo BCT Biotechnologies, LLC; Lakewood Colorado

Funder

U.S. Department of Defense

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12894/fullpdf

Reference51 articles.

1. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital;Borgman;J Trauma,2007

2. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients;Holcomb;Ann Surg,2008

3. The impact of platelet transfusion in massively transfused trauma patients;Inaba;J Am Coll Surg,2010

4. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients;Rowell;J Trauma,2011

5. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion;Sperry;J Trauma,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen reduction of whole blood: Supplementing fibrinogen partly corrects clot formation in a massive transfusion model;Transfusion;2021-03-21

2. An experimental study on riboflavin photosensitization treatment for inactivation of circulating HCT116 tumor cells;Journal of Photochemistry and Photobiology B: Biology;2019-07

3. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026);Transfusion;2019-05-29

4. The pathogen‐reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases;Vox Sanguinis;2019-02-19

5. Red Blood Cells Derived from Whole Blood Treated with Riboflavin and UV Light Maintain Adequate Cell Quality through 21 Days of Storage;Transfusion Medicine and Hemotherapy;2019